The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
Open accessAbstract
Ashwagandha (Withania Somnifera, WS), belonging to the family Solanaceae, is an Ayurvedic herb known worldwide for its numerous beneficial health activities since ancient times. This medicinal plant provides benefits against many human illnesses such as epilepsy, depression, arthritis, diabetes, and palliative effects such as analgesic, rejuvenating, regenerating, and growth-promoting effects. Several clinical trials of the different parts of the herb have demonstrated safety in patients suffering from these diseases. In the last two decades, an active component of Withaferin A (WFA) has shown tremendous cytotoxic activity suggesting its potential as an anti-carcinogenic agent in treatment of several cancers. In spite of enormous progress, a thorough elaboration of the proposed mechanism and mode of action is absent. Herein, we provide a comprehensive review of the properties of WS extracts (WSE) containing complex mixtures of diverse components including WFA, which have shown inhibitory properties against many cancers, (breast, colon, prostate, colon, ovarian, lung, brain), along with their mechanism of actions and pathways involved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930 · cited 2×
“Lung cancer is also classified based on the driver oncogenic mutation such as EGFR (epidermal growth factor receptor) mutation (20%), ALK (anaplastic lymphoma kinase) rearrangement (<5%), KRAS (20%) and p53 mutations (50%) [88].”
BackgroundBiswal, B. M., Sulaiman, S. A., Ismail, H. C., Zakaria, H., & Musa, K. I. (2013) · Integrative Cancer Therapies · doi:10.1177/1534735412464551 · Cited by 131
Ziegenfuss, T. N., Kedia, A. W., Sandrock, J. E., Raub, B. J., Kerksick, C. M., & Lopez, H. L. (2018) · Nutrients · doi:10.3390/nu10111807 · Cited by 80 · cited 1×
“placebo), 500 mg/d, 12 weeks Improved upper and lower-body strength, and supported a favorable distribution of body mass Well tolerated clinically [10]”
BackgroundAhmed, W., Mofed, D., Zekri, A.-R., El-Sayed, N., Rahouma, M., & Sabet, S. (2018) · Journal of International Medical Research · doi:10.1177/0300060517752022 · Cited by 56
Cited by
Mikulska, P., Malinowska, M., Ignacyk, M., Szustowski, P., Nowak, J., Pesta, K., Szeląg, M., Szklanny, D., Judasz, E., Kaczmarek, G., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041057 · Cited by 324
Comprehensive review of hepatotoxicity associated with traditional Indian Ayurvedic herbs
Philips, C. A., Ahamed, R., Rajesh, S., George, T., Mohanan, M., & Augustine, P. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i9.574 · Cited by 57
Ashwagandha-Associated Acute Liver Failure Requiring Liver Transplantation
Suryawanshi, G., Abdallah, M., Thomson, M., Desai, N., Chauhan, A., & Lim, N. (2023) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001466 · Cited by 18
Metadata
- Authors
- Dutta, R., Khalil, R., Green, R., Mohapatra, S. S., & Mohapatra, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-10-25
- Volume
- 20
- Issue
- 21
- Pages
- 5310
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2981687953
- Cited by
- 195
- References
- 4
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.